Maxcyte annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Maxcyte's debt-to-assets ratio was 0.09 for fiscal 2025.
View full Maxcyte company overview| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.09 | 0.01 | +17.66% |
| 2024 | 2024-12-31 | 0.08 | 0.01 | +7.79% |
| 2023 | 2023-12-31 | 0.07 | 0.01 | +24.43% |
| 2022 | 2022-12-31 | 0.06 | 0.04 | +180.75% |
| 2021 | 2021-12-31 | 0.02 | −0.02 | −49.47% |
| 2020 | 2020-12-31 | 0.04 | — | — |
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.09 | 0.01 | +10.92% |
| Q1 2026 | 2026-03-31 | 0.09 | 0.01 | +9.86% |
| Q4 2025 | 2025-12-31 | 0.09 | 0.01 | +17.66% |
| Q3 2025 | 2025-09-30 | 0.09 | 0.01 | +15.45% |
| Q2 2025 | 2025-06-30 | 0.08 | 0.01 | +14.32% |
| Q1 2025 | 2025-03-31 | 0.08 | 0.01 | +13.26% |
| Q4 2024 | 2024-12-31 | 0.08 | 0.01 | +7.79% |
| Q3 2024 | 2024-09-30 | 0.07 | 0.01 | +22.21% |
| Q2 2024 | 2024-06-30 | 0.07 | 0.01 | +23.28% |
| Q1 2024 | 2024-03-31 | 0.07 | 0.01 | +25.19% |
| Q4 2023 | 2023-12-31 | 0.07 | 0.01 | +24.43% |
| Q3 2023 | 2023-09-30 | 0.06 | 0.00 | +8.35% |
| Q2 2023 | 2023-06-30 | 0.06 | 0.01 | +9.73% |
| Q1 2023 | 2023-03-31 | 0.06 | 0.01 | +18.80% |
| Q4 2022 | 2022-12-31 | 0.06 | 0.04 | +180.75% |
| Q3 2022 | 2022-09-30 | 0.06 | 0.05 | +1335.17% |
| Q2 2022 | 2022-06-30 | 0.05 | 0.04 | +258.26% |
| Q1 2022 | 2022-03-31 | 0.05 | — | — |
| Q4 2021 | 2021-12-31 | 0.02 | −0.02 | −49.47% |
| Q3 2021 | 2021-09-30 | 0.00 | — | — |
| Q2 2021 | 2021-06-30 | 0.02 | — | — |
| Q4 2020 | 2020-12-31 | 0.04 | — | — |
Over the last five fiscal years, Maxcyte's debt-to-assets ratio increased from 0.04 to 0.09, a change of 0.05. The latest reported quarter, Q2 2026, shows 0.09.
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maxcyte source filings ↗